Bringing a drug to market can be a time consuming and costly process for innovators in the life sciences sector. Developing a new drug costs an average of $2 billion, and only 7% of experimental drugs in early-stage trials reach the market, according to the Tufts Center for the Study of Drug Development.
Our healthcare lawyers support life sciences clients throughout the product lifecycle, from research and development to launch. Our lawyers have particular expertise advising medical device and pharmaceutical companies on marketing and promotion rules across the globe, particularly those related to social media. We also help life sciences clients with all aspects of intellectual property registration, protection and enforcement and represent clients in trademark and patent prosecution.
With more than 50 years of experience in the pharmaceutical, healthcare and medical industry, we advise on mergers, acquisitions, spinoffs and joint ventures, helping life sciences clients navigate the regulatory and compliance issues specific to the industry, particularly in emerging markets where the industry is undergoing double-digit growth.